samedan logo
 
 
 
spacer
home > pmps > winter 2003 > editor's letter
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Editor's Letter

As PMPS passes its five year milestone may I welcome you to this Winter 2003 issue. So much has happened in the world of pharmaceutical manufacturing since the first issue in 1998, especially with the gathering pace of outsourcing. I'm delighted to be able to look back with a sense of pride at how much has been achieved, while looking forward to the next five years with anticipation. PMPS has kept in tune with developments as the market has steadily grown, with an increase in the number of contract manufacturing organisations (CMOs), business transactions and the number of employees working in the sector. The type of contract business has also diversified, with a trend towards an increase in the outsourcing of development activities needed to get products to market

faster. I say there has been a steady growth because it would be a gross exaggeration to suggest a growth rate of the market for development outsourcing of 25 per cent per year.

Figures of that magnitude, plucked out of thin air create unrealistic expectations and do little to enhance the reputation of this sector. For example, we have seen what happened with biotech when unfulfilled predictions turned sour. I'm conscious of a painful recession in biotech as sentiment plunged from the heady days of the market in 2000, driven as it was by so much hyperbole. Nevertheless, I remain optimistic about outsourcing as we look forward to the next Bio/PharMOS event with an exhibition and conference for manufacturing outsourcing services on 23rd-25th March 2004.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Editor of PMPS, Patricia Lobo rounds up current issues impacting on development and manufacturing in biotech and pharma.
spacer
Dr Patricia Lobo
spacer
spacer
spacer
Joanne Glover
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting The Efficacy And Safety of Cefiderocol For The Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adults With Limited Treatment Options

Shionogi announces publication of data from two of its clinical trials; APEKS-NP and CREDIBLE-CR in the journal The Lancet Infectious Diseases.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement